Market Tracker

07/31 3:10am ET

Pharmacyclics Inc (NASDAQ:PCYC)

123.42
Data as of Jul 30
 -1.33 / -1.07%
Today’s Change
82.51
Today|||52-Week Range
154.89
+16.68%
Year-to-Date

Today’s Trading

Previous close124.75
Today’s open124.44
Day’s range122.01 - 125.66
Volume1,284,571
Average volume (3 months)1,325,633
Market cap$9.4B
Dividend yield--
Data as of 3:59pm ET, 07/30/2014

Growth & Valuation

Earnings growth (last year)+411.76%
Earnings growth (this year)-95.25%
Earnings growth (next 5 years)+188.00%
Revenue growth (last year)+217.32%
P/E ratio69.7
Price/Sales29.59
Price/Book14.74

Competitors

 Today’s
change
Today’s
% change
BMRNBiomarin Pharmaceuti...+0.06+0.10%
HSPHospira Inc+4.31+8.30%
ENDPEndo International P...+1.09+1.64%
SLXPSalix Pharmaceutical...+3.78+2.87%
Data as of 4:00pm ET, 07/30/2014

Financials

Next reporting dateSeptember 15, 2014
EPS forecast (this quarter)-$0.17
Annual revenue (last year)$260.2M
Annual profit (last year)$67.0M
Net profit margin25.76%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Robert W. Duggan
Chief Operating Officer
Mahkam Zanganeh
Corporate headquarters
Sunnyvale, California

Forecasts